SEARCH

SEARCH BY CITATION

References

  • 1
    Hedin C , Whelan K , Lindsay JO . Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc 2007; 66: 30715.
  • 2
    Nagalingam NA , Lynch SV . Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2012; 18: 96884.
  • 3
    DuPont AW , DuPont HL . The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol 2011; 8: 52331.
  • 4
    Sartor RB . Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 57794.
  • 5
    Vernia P . Butyrate in the treatment of ulcerative colitis. Digest Liver Dis 2007; 1(Suppl. 1): 2730.
  • 6
    Hamer HM , Jonkers DM , Vanhoutvin SA , et al. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clin Nutr 2010; 29: 73844.
  • 7
    Talley NJ , Abreu MT , Achkar JP , et al. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol 2011; 106: S225.
  • 8
    Mowat C , Cole A , Windsor A , et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011; 60: 571607.
  • 9
    Bernstein CN , Loftus EV Jr , Ng SC , et al. Hospitalisations and surgery in Crohn's disease. Gut 2012; 61: 6229.
  • 10
    Lix LM , Graff LA , Walker JR , et al. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis 2008; 14: 157584.
  • 11
    Meijer BJ , Dieleman LA . Probiotics in the treatment of human inflammatory bowel diseases: update 2011. J Clin Gastroenterol 2011; 45: S13944.
  • 12
    Benjamin JL , Hedin CR , Koutsoumpas A , et al. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut 2011; 60: 9239.
  • 13
    Gough E , Shaikh H , Manges AR . Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infec Dis 2011; 53: 9941002.
  • 14
    Borody TJ , Khoruts A . Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2011; 9: 8896.
  • 15
    Landy J , Al-Hassi HO , McLaughlin SD , et al. Review article: faecal transplantation therapy for gastrointestinal disease. Aliment Pharmacol Ther 2011; 34: 40915.
  • 16
    Eiseman B , Silen W , Bascom GS , et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44: 8549.
  • 17
    Guo B , Harstall C , Louie T , et al. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther 2012; 35: 86575.
  • 18
    Sinh P , Barrett TA , Yun L . Clostridium difficile infection and inflammatory bowel disease: a review. Gastroenterol Res Prac 2011; 2011: 136064.
  • 19
    Nguyen GC , Kaplan GG , Harris ML , et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008; 103: 144350.
    Direct Link:
  • 20
    Higgins JPT , Green S , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, March 2011. Available at: http://www.cochrane-handbook.org.
  • 21
    Liberati A , Altman DG , Tetzlaff J , et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009; 151: W6594.
  • 22
    Aas J , Gessert CE , Bakken JS . Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infec Dis 2003; 36: 5805.
  • 23
    Grehan MJ , Borody TJ , Leis SM , et al. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 2010; 44: 55161.
  • 24
    Borody TJ , Wettstein AR , Leis S , et al. Clostridium difficile complicating inflammatory bowel disease: pre- and post-treatment findings. Gastroenterology 2008; 134: A361A361.
  • 25
    Wettstein A , Borody TJ , Leis SM , et al. Fecal bacteriotherapy - an effective treatment for relapsing symptomatic clostridium difficile infection. Paris: United European Gastroenterology Federation, 2007.
  • 26
    Borody TJ , George L , Andrews P , et al. Bowel-flora alteration – a potential cure for inflammatory bowel-disease and irritable bowel syndrome. Med J Australia 1989; 150: 604604.
  • 27
    Mellow M , Kanatzar A . Colonoscopic fecal bacteriotherapy in the treatment of recurrent Clostridium difficile infection – results and follow-up. Am J Gastroenterol 2010; 105: S135S135.
  • 28
    Borody T , Campbell J , Torres M , et al. Reversal of idiopathic thrombocytopenic purpura [ITP] with fecal microbiota transplantation [FMT]. Am J Gastroenterol 2011; 106: S352S352.
  • 29
    You D , Johnson M , Duplessis C , et al. Successful use of fecal bacteriotherapy in severe Crohn's colitis and refractory Clostridium difficile infection. Am J Gastroenterol 2011; 106: S315S315.
  • 30
    Borody T , Torres M , Campbell J , et al. Reversal of inflammatory bowel disease (IBD) with recurrent faecal microbiota transplants (FMT). Am J Gastroenterol 2011; 106: S366.
  • 31
    Borody T , Leis S , McGrath K , et al. Treatment of chronic constipation and colitis using human probiotic infusions. In: Probiotics, Prebiotics and New Foods Conference, Universita Urbaniana, Rome; September 2–4, 2001.
  • 32
    Vermeire S , Joossens M , Verbeke K , et al. Pilot study on the safety and efficacy of faecal microbiota transplantation in refractory crohn's disease. Gastroenterology 2012; 142: S360.
  • 33
    Zainah H , Silverman A . Fecal bacteriotherapy: a case report in an immunosuppressed patient with ulcerative colitis and recurrent Clostridium difficile infection. Case Rep Infect Dis 2012; 2012: 810943.
  • 34
    Borody TJ , Warren EF , Leis S , et al. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003; 37: 427.
  • 35
    Bennet JD , Brinkman M . Treatment of ulcerative-colitis by implantation of normal colonic flora. Lancet 1989; 1: 164164.
  • 36
    Angelberger S , Lichtenberger C , Gratzer C , et al. Fecal transplantation in patients with moderately to severely chronic active ulcerative colitis (UC). In ECCO Conference Abstracts 2012. p. P374.
  • 37
    Watson JB , Habr F , Kelly C . First reported complication of fecal microbiota transplant: ulcerative colitis flare after FMT for relapsing Clostridium difficile infection. Gastroenterology 2012; 142: S540.
  • 38
    Neelakanta A , Moudgal V , Upadhyay N , et al. Successful treatment of refractory Clostridium difficile infection(CDI) with intestinal microbiotatransplant (IMT) in two patients with inflammatory bowel disease (IBD) and its effects on IBD. Gastroenterology 2012; 142: S395.
  • 39
    Parkes GC , Sanderson JD , Whelan K . The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea. Lancet Infec Dis 2009; 9: 23744.
  • 40
    Khoruts A , Dicksved J , Jansson JK , et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010; 44: 35460.
  • 41
    Gustafsson A , Berstad A , Lund-Tonnesen S , et al. The effect of faecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhoea. Scand J Gastroenterol 1999; 34: 5806.
  • 42
    Gustafsson A , Lund-Tonnesen S , Berstad A , et al. Faecal short-chain fatty acids in patients with antibiotic-associated diarrhoea, before and after faecal enema treatment. Scand J Gastroenterol 1998; 33: 7217.
  • 43
    Chang JY , Antonopoulos DA , Kalra A , et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008; 197: 4358.
  • 44
    Ng SC , Benjamin JL , McCarthy NE , et al. Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in crohn's disease. Inflamm Bowel Dis 2011; 17: 202737.
  • 45
    Sokol H , Pigneur B , Watterlot L , et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105: 167316.
  • 46
    Naidoo K , Gordon M , Fagbemi AO , et al. Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2011; 12: CD007443.
  • 47
    Casellas F , Borruel N , Torrejon A , et al. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol Ther 2007; 25: 10617.
  • 48
    Manichanh C , Reeder J , Gibert P , et al. Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res 2010; 20: 14119.
  • 49
    Glauser W . Risk and rewards of fecal transplants. Can Med Assoc J 2011; 183: 5412.
  • 50
    Kelly C , de Leon L , Kerstetter D , et al. Barriers to greater utilization of fecal bacteriotherapy for chronic Clostridium difficile infection. Am J Gastroenterol 2010; 105: S1356.
  • 51
    Kahn SA , Gorawara-Bhat R , Rubin DT . Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we? Inflamm Bowel Dis 2012; 18: 67684.
  • 52
    Kahn SA , Vachon AI , Marks JA , et al. Patient perceptions of fecal microbiota transplantation for ulcerative colitis. Gastroenterology 2012; 142: S357.
  • 53
    Joossens M , Huys G , Cnockaert M , et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011; 60: 6317.
  • 54
    Hedin CR , Stagg AJ , Whelan K , et al. Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention. Gut 2012; 61: 3118.
  • 55
    Ioannidis JP . Adverse events in randomized trials: neglected, restricted, distorted, and silenced. Arch Intern Med 2009; 169: 17379.
  • 56
    Bakken JS , Borody T , Brandt LJ , et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011; 9: 10449.
  • 57
    Stange EF , Travis SP , Vermeire S , et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008; 2: 123.
  • 58
    Van Assche G , Dignass A , Panes J , et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010; 4: 727.